Magno Sanol Uno

Magnesium, the active ingredient in Magno Sanol Uno, is a mineral supplement presented as an oral supplement for oral use. It helps correct magnesium deficiency and supports normal neuromuscular and cardiovascular function in adults and children when indicated. GNH USA supplies Magno Sanol Uno as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magno Sanol Uno provides supplemental magnesium to address conditions linked to low magnesium levels. - Magnesium deficiency: restores normal serum magnesium concentrations. - Hypomagnesemia: supports recovery of muscle strength and nerve function. - Muscle cramps: reduces frequency and intensity of involuntary contractions. - Constipation: acts as an osmotic laxative to promote bowel regularity.

Magnesium supplementation may be associated with several adverse reactions.

Common Side Effects: - Diarrhea: loose stools occurring after oral intake. - Abdominal discomfort: mild stomach pain or cramping. - Nausea: feeling of queasiness. - Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects: - Hypermagnesemia: elevated blood magnesium causing weakness, low blood pressure, or cardiac arrhythmia. - Irregular heartbeat: palpitations or arrhythmias in susceptible individuals. - Respiratory depression: slowed breathing in severe overdose. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing.

When considering Magno Sanol Uno, several safety measures are recommended. - Renal function assessment: evaluate kidney performance before initiating therapy. - Serum magnesium monitoring: check levels periodically, especially in high‑risk patients. - Concomitant digoxin use: monitor for enhanced drug effects. - Cardiac conduction disorders: use with caution in patients with heart block. - Pregnancy and lactation: consult a healthcare professional before use. Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Magnesium can affect the absorption or activity of several medicines.

Major Interactions (Avoid): - Potassium‑sparing diuretics (e.g., amiloride): risk of additive hypermagnesemia. - Calcium channel blockers: may potentiate cardiovascular effects.

Moderate Interactions (Monitor Closely): - Oral bisphosphonates: reduced absorption; separate dosing by at least 2 hours. - Tetracycline or fluoroquinolone antibiotics: decreased bioavailability; stagger administration. - Levothyroxine: diminished thyroid hormone absorption; separate dosing. - Digoxin: possible increase in serum concentration; monitor levels.